Family & Friends - the Significance of a Significant Other in Treatment

Obesity Clinical Trial

Official title:

Conservative Treatment of Obesity at Røros Rehabilitation Centre - A Randomised Trial

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01238354
• Other study ID #: RSSO-2010/2
• Status: Completed
• Phase: N/A
• First received: November 9, 2010
• Last updated: June 14, 2016
• Start date: November 2010
• Est. completion date: December 2014

Study information

• Verified date: June 2016
• Source: Norwegian University of Science and Technology
• Contact: n/a
• Is FDA regulated: No
• Health authority: Norway: Ethics Committee
• Study type: Interventional

Clinical Trial Summary

This study focuses on the difficulties to maintain a weight loss and behavioural change after having been in a institutional intermittent weight loss programme.

We explore if including a member of the family or a close friend in the treatment influences weight loss maintenance after completion of the programme.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 80
• Est. completion date: December 2014
• Est. primary completion date: December 2014
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 18 Years to 50 Years

Eligibility

Inclusion Criteria:

• Morbid obesity

• 18-50 years of age

• Having a relative or close friend who is willing to participate

Exclusion Criteria:

• Pregnancy

• Serious mental illness

• Severe overeating behaviour

• Significant reduced physical functioning

• Having undergone bariatric surgery earlier

• Serious heart disease

Study Design

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Health Services Research

Related Conditions & MeSH terms

• Obesity

Intervention

Behavioral:
• With friend

• Without friend

Locations

Country	Name	City	State
Norway	Roros Rehabiliteringssenter	Roros

Sponsors (1)

Lead Sponsor	Collaborator
Norwegian University of Science and Technology

Country where clinical trial is conducted

Norway, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Maintenance of weight loss		2 years after termination of programme	No